Biclique | HIV protein | Human protein | GO term (bp) | GO term (cc) | GO term (mf) | KEGG pathway |
---|---|---|---|---|---|---|
1 | Tat Vpr env_gp120 matrix | BCL2 CASP3 TP53 IFNG IFNG IL10 IL2 IL6 MAPK1 NFKB1 PARP1 FOS JUN TNF | Regulation of apoptosis (GO: 0042981) (3.1E-11) | Nucleoplasm (GO:0005654) (6.8E-5) | Promoter binding (GO:0010843) (1.7E-5) | T cell receptor signaling pathway (1.2E-9) |
2 | Nef Tat env_gp120env_gp160 | BCL2 ICAM1 IFNG IL1B IL2 IL6 MAPK1 MAPK3 FOS JUN | Positive regulation of nitrogen compound metabolic process (GO: 0051173) (1.8E-8) | Extracellular space (GO:0005615) (8.3E-4) | Cytokine activity (GO:0005125) (2.6E-4) | Toll-like receptor signaling pathway (3.3E-7) |
3 | Nef Vpr env_gp120env_gp160 | CD4 BCL2 IFNG IL2 IL6 MAPK14 MAPK1 FOS JUN | Positive regulation of macromolecule metabolic process (GO:0010604) (2.5E-10) | Nucleoplasm (GO:0005654) (1.4E-2) | Protein dimerizationactivity (GO:0046983)(3.5E-3) | T cell receptor signaling pathway (2.2E-9) |
4 | Nef Tat Vpr env_gp120env_gp160 | BCL2 IFNG IL2 IL6 MAPK1 FOS JUN | Positive regulation of macromolecule metabolic process (GO:0010604) (6.4E-8) | Extracellular space (GO:0005615) (3.7E-2) | Cytokine activity (GO:0005125) (3.2E-3) | T cell receptor signalingpathway (2.8E-6) |
5 | Tat Vpr env_gp120env_gp160 | BCL2 CYCS IFNG IL2 IL6 MAPK1 FOS JUN | Regulation of apoptosis (GO:0042981) (2.9E-7) | Protein phosphatase type 2A complex (GO:0000159) (1.1E-2) | Cytokine activity (GO:0005125) (4.5E-3) | Colorectal cancer (2.3E-6) |
6 | Nef Tat env_gp120env_gp41 | CCL5 IFNG IL1B IL10 IL2 IL2RA IL6 TNF | Leukocyte migration (GO:0050900) (2.3E-11) | Extracellular space (GO:0005615) (1.6E-7) | Cytokine activity(GO:0005125) (7.4E-11) | Cytokine-cytokinereceptor interaction (8.9E-10) |
7 | Nef Tat Vpr env_gp120env_gp41 | IFNG IL10 IL2 IL6 TNF | Regulation of immunoglobulinproduction (GO:0002637) (1.1E-11) | Extracellular space (GO:0005615) (8.2E-6) | Cytokine activity (GO:0005125) (4.9E-8) | Allograft rejection (1.3E-6) |
8 | Tat env_gp120 env_gp160 env_gp41 | IL1A IL1B IL2 IL6 LCK | Positive regulation of protein transport (GO:0051222) (4.6E-7) | Extracellular space (GO:0005615) (5.9E-4) | Cytokine activity (GO:0005125) (1.3E-5) | Graft-versus-host disease(1.7E-6) |
9 | Nef Tat env_gp120 matrix | CCL3 IFNG IL6 TNF | Positive regulation of protein aminoacid phosphorylation(GO:0001934) (1.8E-9) | Extracellular space (GO:0005615) (8.2E-6) | Cytokine activity (GO:0005125) (4.9E-8) | Allograft rejection (1.3E-6) |
10 | Nef Tat Vpr env_gp120 env_gp41 matrix | IFNG IL6 TNF | Regulation of chemokine biosynthetic process (GO:0045073) (4.9E-7) | Extracellular space (GO:0005615) (2.9E-3) | Cytokine activity (GO:0005125) (2.2E-4) | Graft-versus-host disease(5.7E-5) |
11 | Tat Vpr env_gp120 retropepsin | BCL2 CASP3 CYCS PARP1 | B cell homeostasis (GO:0001782) (2.4E-3) | Protein phosphatase type 2A complex (GO:0000159) (4.7E-3) | not found | Amyotrophic lateralsclerosis (ALS) (3.2E-4) |
12 | Tat Vpr env_gp120 matrix | CCL3 IFNG IL6 TNF | Regulation of chemokine biosynthetic process (GO:0045073) (1.5E-6) | Extracellular space (GO:0005615) (1.5E-4) | Cytokine activity (GO:0005125) (3.3E-6) | Cytokine-cytokine receptor interaction (1.4E-4) |
13 | Nef env_gp120 env_gp160 env_gp41 | CD4 IL1B IL2 IL6 | Positive regulation of T cell activation (activation(GO:0050870) (1.7E-7) | Extracellular space (GO:0005615) (8.3E-3) activity (GO:0008083) (4.5E-4) | Graft-versus-hostdisease (1.7E-4) | Â |
14 | Nef Tat Vpr env_gp120 retropepsin | BCL2 CASP3 PARP1 | B cell homeostasis (GO:0050870) (1.7E-7) | Nuclear envelope (GO:0005635) (3.2E-2) | Transcription factorbinding (GO:0008134)(7.7E-2) | Amyotrophic lateralsclerosis (ALS) (2.1E-2) |
15 | Nef Tat env_gp120 env_gp160 env_gp41 | IL1B IL2 IL6 | Positive regulation of immunoglobulinsecretion (GO:0051024)(3.7E-4) | Extracellular space (GO:0005615) (5.4E-2) | Not found | Not found |
16 | Nef Tat Vpr env_gp120 env_gp160 env_gp41 | IL2 IL6 | Positive regulation of immunoglobulin secretion secretion (GO:0051024) (3.7E-4) | Extracellular space (GO:0005615) (5.4E-2) | activity (GO:0008083)(1.2E-2) | Graft-versus-host disease (7.7E-3) |
17 | Nef Vpr Vpu env_gp120 | CD4 CASP3 NFKB1 | Regulation of T cellactivation (GO:0050863)(1.7E-2) | Intracellular organellelumen (GO:0070013)(1.9E-2) | Proteinhomodimerization activity(GO:0042803) (5.1E-2) | Epithelial cell signaling in Helicobacter pyloriinfection (2.7E-2) |
18 | Tat Vpr env_gp120 env_gp160 retropepsin | BCL2 CYCS | Positive regulation of catalytic activity activity (GO:0043085) (3.8E-2) | Protein phosphatase type 2A complex (GO:0000159) | Amyotrophic lateralsclerosis (ALS) (1.0E-2) | Â |
19 | Nef env_gp160 env_gp41 matrix | CALM1 IL6 | Positive regulation of DNA binding (GO:0043388) (5.2E-3) | Not found | Not found | Not found |